According to AquaBounty's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.21081. At the end of 2023 the company had a P/S ratio of 7.19.
Year | P/S ratio | Change |
---|---|---|
2023 | 7.19 | -58.46% |
2022 | 17.3 | -86.36% |
2021 | 127 | -96.66% |
2020 | > 1000 | 1412.47% |
2019 | 251 | -31.35% |
2018 | 366 | -37.68% |
2017 | 588 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Organovo ONVO | 44.7 | 1,293.29% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | 17.4 | 442.08% | ๐ฌ๐ง UK |
Novavax NVAX | 0.9536 | -70.30% | ๐บ๐ธ USA |
Novocure
NVCR | 3.00 | -6.63% | Jersey |